von Tobias Borgers | Okt. 9, 2019 | Glaxo
In der Tat ist der Rückgang in den Vereinigten Staaten besonders stark ausgeprägt. Hier verliert WPP satte 8,5 Prozent seiner bereinigten Umsätze. Negativ zu Buche schlagen dürften vor allem die deutliche Reduzierung des Mandats von Ford sowie der Verlust des...
von Tobias Borgers | Okt. 8, 2019 | Abbvie
AbbVie Inc. , Bristol-Myers Squibb Co., Pfizer Inc., and three other major pharmaceutical companies funneled more than $680 million into hundreds of nonprofits last year, including many now campaigning against federal legislation to tackle the rising cost of medicine....
von Tobias Borgers | Okt. 8, 2019 | Boehringer
Global Thrombocytopenia Management Market 2019 report contains wide-extending measurable details of Global Thrombocytopenia Management Market, which enables the customer to separate the future maneuver and anticipate right execution. A comprehensive theory of the...
von Tobias Borgers | Okt. 8, 2019 | Bayer
The FDA has approved Novartis’s new eye drug brolucizumab for wet age-related macular degeneration, which will match Bayer’s rival Eylea on price per dose but reduce costs with a less frequent dosing regimen.Novartis’ Beovu (brolucizumab) has matched the performance...
von Tobias Borgers | Okt. 8, 2019 | Boehringer
An extensive analysis of the Global Aerosol Therapy market strategy of the leading companies in the precision of import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report starts by an introduction about the company...
von Tobias Borgers | Okt. 7, 2019 | Abbvie
Market Deeper released a new market study on Global Sevoflurane Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report...
